The Effect of Instrument Assisted Soft Tissue Mobilization on Respiratory Functions in Chronic Obstructive Pulmonary Disease

NCT ID: NCT05023876

Last Updated: 2024-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-14

Study Completion Date

2022-09-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to investigate the effect of instrument-assisted soft tissue mobilization applied to the hamstring muscle on respiratory function in patients with COPDThe patients to be included in the study will be divided into two groups by simple randomization. A group will be given breathing exercises (pursed lip breathing, diaphragmatic breathing and thoracic expansion exercises) as a home program. The other group will be given breathing exercises in the form of a home program in addition to 1 session of EDYM per week. Both groups will be evaluated before and 4 weeks after treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD Pulmonary Function Soft Tissue Mobilization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IASTM group

Group Type EXPERIMENTAL

Respiratory Exercise

Intervention Type OTHER

Respiratory Exercise

Control Group

Group Type EXPERIMENTAL

IASTM+respiratory Exercise

Intervention Type OTHER

Instrument assisted soft tissue mobilization

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IASTM+respiratory Exercise

Instrument assisted soft tissue mobilization

Intervention Type OTHER

Respiratory Exercise

Respiratory Exercise

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with GOLD stage I-II COPD
* Between the ages of 40-65
* COPD in stable period
* No other respiratory disease that impairs respiratory functions such as asthma
* Knee flexion angle of 15 degrees and above in the hamstring muscle shortness test,
* Individuals without musculoskeletal problems in their lower extremities were included.

Exclusion Criteria

* COPD patients who receive home oxygen therapy or who need oxygen therapy frequently
* COPD exacerbation, hospitalization with acute exacerbation in the last 15 days
* Pregnancy
* Kyphoscoliosis, advanced postural disorder
* Prior thoracic surgery
* Advanced heart failure
* Patients with primary pulmonary hypertension or have had a pulmonary embolism,
* Having serious neurological diseases such as Parkinson's, hemiplegia, multiple sclerosis,
* Neuromuscular disease
* Having dementia, Alzheimer's or advanced cognitive problems,
* Diagnosed with lung cancer or other malignancy,
* People with morbid obesity will not be included in the study.
Minimum Eligible Age

40 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Okan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emine Atıcı

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Emine

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.